Luveris

Luveris is a medication containing lutropin alfa, used for reproductive health support. It is administered subcutaneously and is manufactured by Merck Europe B.V.

Luveris is primarily used in assisted reproductive technologies to support ovulation and fertility treatments. It mimics the action of natural luteinizing hormone, aiding in the development and release of eggs from the ovaries. This medication is often part of protocols for women undergoing in vitro fertilization (IVF) or other fertility treatments.

Common effects of Luveris may include mild injection site reactions such as redness, swelling, or discomfort. Some users might experience headaches, abdominal pain, or breast tenderness. These effects are generally mild and temporary.

Luveris should be handled with care, ensuring proper storage and administration as directed. It is important to follow the healthcare provider's instructions for use. Individuals with known allergies to lutropin alfa or any of the excipients should avoid using this medication.

Luveris may interact with other medications, particularly those that affect hormone levels or reproductive health. It is advisable to consult with a healthcare provider before combining Luveris with other treatments. Alcohol and certain supplements might also influence its effectiveness.